4 news items
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
), with the purpose of commencing planning activities for the evaluation of pelareorep in the treatment of first-line metastatic pancreatic ductal
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
(GCAR), with the purpose of commencing planning activities for the evaluation of pelareorep in the treatment of first-line metastatic pancreatic
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
CADL
15 Mar 24
views as of any subsequent date.This post contains sponsored content. This content is for informational purposes only and is not intended
Moving Fast: Candel's (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
CADL
28 Feb 24
.This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.Contact
- Prev
- 1
- Next